speb/financial-data huggingface dataset:
FNV.TO balance_sheet (annual, 2023-12-31) — Retained Earnings: 212300000.00
FNV.TO income_statement (annual, 2023-12-31) — Salaries And Wages: 15100000.00
FNV.TO cash_flow (annual, 2023-12-31) — Sale Of Investment: 2000000.00
FNV.TO cash_flow (annual, 2023-12-31) — Sale Of PPE: 7000000.00
FNV.TO income_statement (annual, 2023-12-31) — Selling General And Administration: 27900000.00
FNV.TO balance_sheet (annual, 2023-12-31) — Share Issued: 192175042.00
FNV.TO income_statement (annual, 2023-12-31) — Special Income Charges: -1166700000.00
FNV.TO cash_flow (annual, 2023-12-31) — Stock Based Compensation: 5500000.00
FNV.TO balance_sheet (annual, 2023-12-31) — Stockholders Equity: 5769100000.00
FNV.TO balance_sheet (annual, 2023-12-31) — Tangible Book Value: 5769100000.00
FNV.TO income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -460840000.00
FNV.TO income_statement (annual, 2023-12-31) — Tax Provision: 102200000.00
FNV.TO income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.40
FNV.TO balance_sheet (annual, 2023-12-31) — Total Assets: 5994100000.00
FNV.TO balance_sheet (annual, 2023-12-31) — Total Capitalization: 5769100000.00
FNV.TO balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 5769100000.00
FNV.TO income_statement (annual, 2023-12-31) — Total Expenses: 480300000.00
FNV.TO balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 225000000.00
FNV.TO balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 4378800000.00
FNV.TO balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 185800000.00
FNV.TO income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -428000000.00
FNV.TO income_statement (annual, 2023-12-31) — Total Other Finance Cost: 2800000.00
FNV.TO balance_sheet (annual, 2023-12-31) — Total Tax Payable: 8300000.00
FNV.TO income_statement (annual, 2023-12-31) — Total Unusual Items: -1152100000.00
FNV.TO income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -1152100000.00
FNV.TO balance_sheet (annual, 2023-12-31) — Tradeand Other Payables Non Current: 0.00
FNV.TO cash_flow (annual, 2023-12-31) — Unrealized Gain Loss On Investment Securities: -11300000.00
FNV.TO balance_sheet (annual, 2023-12-31) — Working Capital: 1576100000.00
FNV.TO income_statement (annual, 2023-12-31) — Write Off: 1173300000.00
FNV.TO cash_flow (quarterly, 2024-09-30) — Change In Other Current Liabilities: 11200000.00
FNV.TO cash_flow (quarterly, 2024-09-30) — Change In Prepaid Assets: 8200000.00
FNV.TO cash_flow (quarterly, 2024-09-30) — Common Stock Dividend Paid: -61100000.00
FNV.TO cash_flow (quarterly, 2024-09-30) — Long Term Debt Payments: 0.00
FNV.TO cash_flow (quarterly, 2024-09-30) — Net Issuance Payments Of Debt: 0.00
FNV.TO cash_flow (quarterly, 2024-09-30) — Net Long Term Debt Issuance: 0.00
FNV.TO cash_flow (quarterly, 2024-09-30) — Net Other Investing Changes: -24700000.00
FNV.TO cash_flow (quarterly, 2024-09-30) — Repayment Of Debt: 0.00
FNV.TO income_statement (annual, 2024-12-31) — +Operating Expense: 34600000.00
FNV.TO income_statement (annual, 2024-12-31) — +Total Revenue: 1113600000.00
FNV.TO balance_sheet (annual, 2024-12-31) — Accounts Payable: 5100000.00
FNV.TO balance_sheet (annual, 2024-12-31) — Accounts Receivable: 151800000.00
FNV.TO balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -5233500000.00
FNV.TO balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -5233500000.00
FNV.TO balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 23000000.00
FNV.TO cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 0.00
FNV.TO balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 324800000.00
FNV.TO balance_sheet (quarterly, 2024-12-31) — Available For Sale Securities: 324800000.00
FNV.TO income_statement (annual, 2024-12-31) — Average Dilution Earnings: 0.00
FNV.TO income_statement (annual, 2024-12-31) — Basic Average Shares: 192400000.00
FNV.TO income_statement (quarterly, 2024-12-31) — Basic Average Shares: 192500000.00
FNV.TO income_statement (annual, 2024-12-31) — Basic EPS: 2.87
FNV.TO income_statement (quarterly, 2024-12-31) — Basic EPS: 0.91
FNV.TO cash_flow (annual, 2024-12-31) — Beginning Cash Position: 1421900000.00
FNV.TO cash_flow (annual, 2024-12-31) — Capital Expenditure: -408000000.00
FNV.TO balance_sheet (annual, 2024-12-31) — Capital Stock: 5769100000.00
FNV.TO balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 1451300000.00
FNV.TO balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 1451300000.00
FNV.TO cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -242400000.00
FNV.TO balance_sheet (annual, 2024-12-31) — Cash Equivalents: 663200000.00
FNV.TO balance_sheet (quarterly, 2024-12-31) — Cash Equivalents: 663200000.00
FNV.TO balance_sheet (annual, 2024-12-31) — Cash Financial: 788100000.00
FNV.TO balance_sheet (quarterly, 2024-12-31) — Cash Financial: 788100000.00
FNV.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -240400000.00
FNV.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -537300000.00
FNV.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 829500000.00
FNV.TO cash_flow (annual, 2024-12-31) — Change In Inventory: 15600000.00
FNV.TO cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 15600000.00
FNV.TO cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: 46600000.00
FNV.TO cash_flow (quarterly, 2024-12-31) — Change In Other Current Liabilities: 19700000.00
FNV.TO cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 46600000.00
FNV.TO cash_flow (annual, 2024-12-31) — Change In Receivables: -40800000.00
FNV.TO cash_flow (annual, 2024-12-31) — Change In Working Capital: 21400000.00
FNV.TO cash_flow (annual, 2024-12-31) — Changes In Cash: 51800000.00
FNV.TO balance_sheet (annual, 2024-12-31) — Common Stock: 5769100000.00
FNV.TO cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -242400000.00
FNV.TO cash_flow (quarterly, 2024-12-31) — Common Stock Dividend Paid: -62100000.00
FNV.TO balance_sheet (annual, 2024-12-31) — Common Stock Equity: 5996600000.00
FNV.TO income_statement (annual, 2024-12-31) — Cost Of Revenue: 354300000.00
FNV.TO balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 23600000.00
FNV.TO balance_sheet (quarterly, 2024-12-31) — Current Accrued Expenses: 23600000.00
FNV.TO balance_sheet (annual, 2024-12-31) — Current Assets: 1716800000.00
FNV.TO balance_sheet (annual, 2024-12-31) — Current Liabilities: 67500000.00
FNV.TO cash_flow (annual, 2024-12-31) — Deferred Income Tax: 66300000.00
FNV.TO cash_flow (annual, 2024-12-31) — Deferred Tax: 66300000.00
FNV.TO cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 225300000.00
FNV.TO income_statement (annual, 2024-12-31) — Diluted Average Shares: 192600000.00
FNV.TO income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 192800000.00
FNV.TO income_statement (annual, 2024-12-31) — Diluted EPS: 2.87
FNV.TO income_statement (quarterly, 2024-12-31) — Diluted EPS: 0.91
FNV.TO income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 552100000.00
FNV.TO income_statement (annual, 2024-12-31) — EBIT: 764000000.00
FNV.TO income_statement (annual, 2024-12-31) — EBITDA: 989300000.00
FNV.TO cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -22400000.00
FNV.TO cash_flow (annual, 2024-12-31) — End Cash Position: 1451300000.00
FNV.TO balance_sheet (annual, 2024-12-31) — Financial Assets: 700000.00
FNV.TO balance_sheet (quarterly, 2024-12-31) — Financial Assets: 700000.00
FNV.TO cash_flow (annual, 2024-12-31) — Financing Cash Flow: -240400000.00
FNV.TO cash_flow (annual, 2024-12-31) — Free Cash Flow: 421500000.00
FNV.TO cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 6000000.00
FNV.TO cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: -8200000.00
FNV.TO income_statement (annual, 2024-12-31) — Gain On Sale Of Ppe: 8200000.00
FNV.TO income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -20700000.00
FNV.TO balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -282000000.00
FNV.TO income_statement (annual, 2024-12-31) — General And Administrative Expense: 34600000.00
FNV.TO balance_sheet (annual, 2024-12-31) — Gross PPE: 9342800000.00
FNV.TO income_statement (annual, 2024-12-31) — Gross Profit: 759300000.00
FNV.TO income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 0.00
FNV.TO cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 73800000.00
FNV.TO balance_sheet (annual, 2024-12-31) — Income Tax Payable: 38800000.00
FNV.TO income_statement (annual, 2024-12-31) — Insurance And Claims: 900000.00
FNV.TO income_statement (annual, 2024-12-31) — Interest Expense: 100000.00
FNV.TO income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 100000.00
FNV.TO income_statement (annual, 2024-12-31) — Interest Income: 60600000.00
FNV.TO income_statement (annual, 2024-12-31) — Interest Income Non Operating: 60600000.00
FNV.TO cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 2100000.00
FNV.TO balance_sheet (annual, 2024-12-31) — Inventory: 96800000.00
FNV.TO balance_sheet (annual, 2024-12-31) — Invested Capital: 5996600000.00
FNV.TO cash_flow (annual, 2024-12-31) — Investing Cash Flow: -537300000.00
FNV.TO balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 324800000.00
FNV.TO balance_sheet (quarterly, 2024-12-31) — Investmentin Financial Assets: 324800000.00
FNV.TO balance_sheet (annual, 2024-12-31) — Investments And Advances: 324800000.00
FNV.TO cash_flow (annual, 2024-12-31) — Issuance Of Debt: 0.00
FNV.TO balance_sheet (annual, 2024-12-31) — Loans Receivable: 5900000.00
FNV.TO balance_sheet (quarterly, 2024-12-31) — Loans Receivable: 5900000.00
FNV.TO cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 0.00
FNV.TO cash_flow (annual, 2024-12-31) — Long Term Debt Payments: 0.00
FNV.TO balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 400000.00
FNV.TO balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 400000.00
FNV.TO cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: 12900000.00
FNV.TO income_statement (annual, 2024-12-31) — Net Income: 552100000.00
FNV.TO income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 552100000.00
FNV.TO income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 552100000.00
FNV.TO income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 552100000.00
FNV.TO income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 552100000.00
FNV.TO cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 552100000.00
FNV.TO income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 552100000.00
FNV.TO income_statement (annual, 2024-12-31) — Net Interest Income: 58000000.00
FNV.TO cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -51200000.00
FNV.TO cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 0.00
FNV.TO cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 0.00
FNV.TO income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 58000000.00
FNV.TO cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -800000.00
FNV.TO cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -89300000.00
FNV.TO cash_flow (quarterly, 2024-12-31) — Net Other Investing Changes: 0.00
FNV.TO balance_sheet (annual, 2024-12-31) — Net PPE: 4109300000.00
FNV.TO cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -396800000.00
FNV.TO balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 5996600000.00
FNV.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 30800000.00
FNV.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 238000000.00
FNV.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 30800000.00
FNV.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 238000000.00
FNV.TO balance_sheet (annual, 2024-12-31) — Non Current Note Receivables: 104100000.00
FNV.TO balance_sheet (quarterly, 2024-12-31) — Non Current Note Receivables: 104100000.00
FNV.TO balance_sheet (annual, 2024-12-31) — Non Current Prepaid Assets: 42500000.00
FNV.TO balance_sheet (quarterly, 2024-12-31) — Non Current Prepaid Assets: 42500000.00
FNV.TO income_statement (annual, 2024-12-31) — Normalized EBITDA: 1008100000.00
FNV.TO income_statement (annual, 2024-12-31) — Normalized Income: 565687485.27
FNV.TO cash_flow (annual, 2024-12-31) — Operating Cash Flow: 829500000.00
FNV.TO cash_flow (annual, 2024-12-31) — Operating Gains Losses: 10700000.00
FNV.TO income_statement (annual, 2024-12-31) — Operating Income: 724700000.00
FNV.TO income_statement (annual, 2024-12-31) — Operating Revenue: 1113600000.00
FNV.TO balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 192552695.00
FNV.TO balance_sheet (annual, 2024-12-31) — Other Current Assets: 400000.00
FNV.TO balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -282000000.00
FNV.TO income_statement (annual, 2024-12-31) — Other Gand A: 15200000.00
FNV.TO income_statement (annual, 2024-12-31) — Other Income Expense: -18800000.00
FNV.TO cash_flow (annual, 2024-12-31) — Other Non Cash Items: -51700000.00
FNV.TO balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 1400000.00
FNV.TO balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 8500000.00
FNV.TO balance_sheet (annual, 2024-12-31) — Other Properties: 4500000.00
FNV.TO balance_sheet (quarterly, 2024-12-31) — Other Properties: 4500000.00
FNV.TO income_statement (annual, 2024-12-31) — Other Special Charges: 6300000.00
FNV.TO balance_sheet (annual, 2024-12-31) — Payables: 43900000.00
FNV.TO balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 67500000.00
FNV.TO balance_sheet (annual, 2024-12-31) — Prepaid Assets: 2500000.00
FNV.TO balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 2500000.00
FNV.TO income_statement (annual, 2024-12-31) — Pretax Income: 763900000.00
FNV.TO cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 2800000.00
FNV.TO cash_flow (annual, 2024-12-31) — Purchase Of Investment: -74500000.00
FNV.TO cash_flow (annual, 2024-12-31) — Purchase Of PPE: -408000000.00
FNV.TO balance_sheet (annual, 2024-12-31) — Receivables: 165800000.00
FNV.TO income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 354300000.00
FNV.TO income_statement (annual, 2024-12-31) — Reconciled Depreciation: 225300000.00
FNV.TO cash_flow (annual, 2024-12-31) — Repayment Of Debt: 0.00
FNV.TO balance_sheet (annual, 2024-12-31) — Retained Earnings: 486500000.00
FNV.TO income_statement (annual, 2024-12-31) — Salaries And Wages: 18500000.00
FNV.TO cash_flow (annual, 2024-12-31) — Sale Of Investment: 23300000.00
FNV.TO cash_flow (annual, 2024-12-31) — Sale Of PPE: 11200000.00
FNV.TO income_statement (annual, 2024-12-31) — Selling General And Administration: 34600000.00
FNV.TO balance_sheet (annual, 2024-12-31) — Share Issued: 192552695.00
FNV.TO income_statement (annual, 2024-12-31) — Special Income Charges: 1900000.00
FNV.TO cash_flow (annual, 2024-12-31) — Stock Based Compensation: 5400000.00
FNV.TO balance_sheet (annual, 2024-12-31) — Stockholders Equity: 5996600000.00
FNV.TO balance_sheet (annual, 2024-12-31) — Tangible Book Value: 5996600000.00
FNV.TO income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -5212514.73
FNV.TO income_statement (annual, 2024-12-31) — Tax Provision: 211800000.00
FNV.TO income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.28
FNV.TO balance_sheet (annual, 2024-12-31) — Taxes Receivable: 8100000.00
FNV.TO balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 8100000.00
FNV.TO balance_sheet (annual, 2024-12-31) — Total Assets: 6330400000.00
FNV.TO balance_sheet (annual, 2024-12-31) — Total Capitalization: 5996600000.00
FNV.TO balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 5996600000.00
FNV.TO income_statement (annual, 2024-12-31) — Total Expenses: 388900000.00
FNV.TO balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 333800000.00
FNV.TO balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 4613600000.00
FNV.TO balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 266300000.00
FNV.TO income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 726600000.00
FNV.TO income_statement (annual, 2024-12-31) — Total Other Finance Cost: 2500000.00
FNV.TO balance_sheet (annual, 2024-12-31) — Total Tax Payable: 38800000.00
FNV.TO income_statement (annual, 2024-12-31) — Total Unusual Items: -18800000.00
FNV.TO income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -18800000.00
FNV.TO balance_sheet (annual, 2024-12-31) — Tradeand Other Payables Non Current: 19800000.00
FNV.TO balance_sheet (annual, 2024-12-31) — Working Capital: 1649300000.00
FNV.TO income_statement (annual, 2024-12-31) — Write Off: 0.00
FNV.TO income_statement (quarterly, 2025-03-31) — +Operating Expense: 15100000.00
FNV.TO income_statement (quarterly, 2025-03-31) — +Total Revenue: 368400000.00
FNV.TO balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 30700000.00
FNV.TO balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 160200000.00
FNV.TO balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 17900000.00
FNV.TO income_statement (quarterly, 2025-03-31) — Basic Average Shares: 192600000.00
FNV.TO income_statement (quarterly, 2025-03-31) — Basic EPS: 1.09
FNV.TO cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 1451300000.00
FNV.TO cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -508400000.00
FNV.TO balance_sheet (quarterly, 2025-03-31) — Capital Stock: 5782200000.00
FNV.TO balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 1128100000.00
FNV.TO balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1128100000.00
FNV.TO cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -70200000.00
FNV.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -66800000.00
FNV.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -551000000.00
FNV.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 288900000.00
FNV.TO cash_flow (quarterly, 2025-03-31) — Change In Inventory: 8900000.00
FNV.TO cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 8900000.00
FNV.TO cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: 1400000.00
FNV.TO cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 1400000.00
FNV.TO cash_flow (quarterly, 2025-03-31) — Change In Receivables: -8400000.00
FNV.TO cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 1900000.00
FNV.TO cash_flow (quarterly, 2025-03-31) — Changes In Cash: -328900000.00
FNV.TO balance_sheet (quarterly, 2025-03-31) — Common Stock: 5782200000.00
FNV.TO cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -70200000.00
FNV.TO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 6292500000.00
FNV.TO income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 106900000.00
FNV.TO balance_sheet (quarterly, 2025-03-31) — Current Assets: 1394900000.00
FNV.TO balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 60900000.00
FNV.TO cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 9100000.00
FNV.TO cash_flow (quarterly, 2025-03-31) — Deferred Tax: 9100000.00
FNV.TO cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 68400000.00
FNV.TO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 192900000.00
FNV.TO income_statement (quarterly, 2025-03-31) — Diluted EPS: 1.09
FNV.TO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 209800000.00
FNV.TO income_statement (quarterly, 2025-03-31) — EBIT: 270300000.00
FNV.TO income_statement (quarterly, 2025-03-31) — EBITDA: 338700000.00
FNV.TO cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 5700000.00
FNV.TO cash_flow (quarterly, 2025-03-31) — End Cash Position: 1128100000.00
FNV.TO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -66800000.00
FNV.TO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -219500000.00
FNV.TO cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: -100000.00
FNV.TO cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: -7100000.00
FNV.TO income_statement (quarterly, 2025-03-31) — Gain On Sale Of Ppe: 7100000.00
FNV.TO income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 5700000.00
FNV.TO balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -134000000.00
FNV.TO income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 15100000.00
FNV.TO balance_sheet (quarterly, 2025-03-31) — Gross PPE: 4539000000.00
FNV.TO income_statement (quarterly, 2025-03-31) — Gross Profit: 261500000.00
FNV.TO cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 47500000.00
FNV.TO balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 30200000.00
FNV.TO income_statement (quarterly, 2025-03-31) — Interest Expense: 700000.00
FNV.TO income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 700000.00
FNV.TO income_statement (quarterly, 2025-03-31) — Interest Income: 11100000.00
FNV.TO income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 11100000.00
FNV.TO cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 1000000.00
FNV.TO balance_sheet (quarterly, 2025-03-31) — Inventory: 89400000.00
FNV.TO balance_sheet (quarterly, 2025-03-31) — Invested Capital: 6292500000.00
FNV.TO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -551000000.00
FNV.TO balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 539900000.00
FNV.TO balance_sheet (quarterly, 2025-03-31) — Loans Receivable: 11900000.00
FNV.TO cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -6000000.00
FNV.TO income_statement (quarterly, 2025-03-31) — Net Income: 209800000.00
FNV.TO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 209800000.00
FNV.TO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 209800000.00
FNV.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 209800000.00
FNV.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 209800000.00
FNV.TO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 209800000.00
FNV.TO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 209800000.00
FNV.TO income_statement (quarterly, 2025-03-31) — Net Interest Income: 10400000.00
FNV.TO cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -42600000.00
FNV.TO income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 10400000.00
FNV.TO balance_sheet (quarterly, 2025-03-31) — Net PPE: 4539000000.00
FNV.TO cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -508400000.00
FNV.TO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 6292500000.00
FNV.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 26600000.00
FNV.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 265100000.00
FNV.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 26600000.00
FNV.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 265100000.00
FNV.TO balance_sheet (quarterly, 2025-03-31) — Non Current Note Receivables: 98200000.00
FNV.TO income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 325900000.00
FNV.TO income_statement (quarterly, 2025-03-31) — Normalized Income: 199839169.14
FNV.TO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 288900000.00
FNV.TO cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -13200000.00
FNV.TO income_statement (quarterly, 2025-03-31) — Operating Income: 246400000.00
FNV.TO income_statement (quarterly, 2025-03-31) — Operating Revenue: 368400000.00
FNV.TO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 192648281.00
FNV.TO balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 5300000.00
FNV.TO balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -134000000.00
FNV.TO income_statement (quarterly, 2025-03-31) — Other Gand A: 9400000.00
FNV.TO income_statement (quarterly, 2025-03-31) — Other Income Expense: 12800000.00
FNV.TO cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 10800000.00
FNV.TO balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 54800000.00
FNV.TO balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 8400000.00
FNV.TO income_statement (quarterly, 2025-03-31) — Other Special Charges: 700000.00
FNV.TO balance_sheet (quarterly, 2025-03-31) — Payables: 60900000.00
FNV.TO balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 60900000.00
FNV.TO income_statement (quarterly, 2025-03-31) — Pretax Income: 269600000.00
FNV.TO cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 3400000.00
FNV.TO cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -52300000.00
FNV.TO cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -508400000.00
FNV.TO balance_sheet (quarterly, 2025-03-31) — Receivables: 172100000.00
FNV.TO income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 106900000.00
FNV.TO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 68400000.00
FNV.TO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 626400000.00
FNV.TO income_statement (quarterly, 2025-03-31) — Salaries And Wages: 5700000.00
FNV.TO cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 9700000.00
FNV.TO cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 0.00
FNV.TO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 15100000.00
FNV.TO balance_sheet (quarterly, 2025-03-31) — Share Issued: 192648281.00
FNV.TO income_statement (quarterly, 2025-03-31) — Special Income Charges: 7100000.00
FNV.TO cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 2100000.00
FNV.TO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 6292500000.00
FNV.TO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 6292500000.00
FNV.TO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 2839169.14
FNV.TO income_statement (quarterly, 2025-03-31) — Tax Provision: 59800000.00
FNV.TO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.22
FNV.TO balance_sheet (quarterly, 2025-03-31) — Total Assets: 6653400000.00
FNV.TO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 6292500000.00
FNV.TO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 6292500000.00
FNV.TO income_statement (quarterly, 2025-03-31) — Total Expenses: 122000000.00
FNV.TO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 360900000.00
FNV.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 5258500000.00
FNV.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 300000000.00
FNV.TO income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 253500000.00
FNV.TO balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 30200000.00
FNV.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items: 12800000.00
FNV.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 12800000.00
FNV.TO balance_sheet (quarterly, 2025-03-31) — Tradeand Other Payables Non Current: 26500000.00
FNV.TO balance_sheet (quarterly, 2025-03-31) — Working Capital: 1334000000.00
FNV.TO income_statement (quarterly, 2025-06-30) — +Operating Expense: 8500000.00
FNV.TO income_statement (quarterly, 2025-06-30) — +Total Revenue: 369400000.00
FNV.TO balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 33600000.00
FNV.TO balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 146700000.00
FNV.TO balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 19300000.00
FNV.TO cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: -4100000.00
FNV.TO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 192700000.00
FNV.TO income_statement (quarterly, 2025-06-30) — Basic EPS: 1.28
FNV.TO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 1128100000.00
FNV.TO cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -1360900000.00
FNV.TO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 5789200000.00
FNV.TO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 160300000.00
FNV.TO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 160300000.00
FNV.TO cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -67000000.00
FNV.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -66100000.00
FNV.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -1338100000.00
FNV.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 430300000.00
FNV.TO cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -20000000.00
FNV.TO cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 8100000.00
FNV.TO cash_flow (quarterly, 2025-06-30) — Change In Receivables: 13500000.00
FNV.TO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 1600000.00
FNV.TO cash_flow (quarterly, 2025-06-30) — Changes In Cash: -973900000.00
FNV.TO balance_sheet (quarterly, 2025-06-30) — Common Stock: 5789200000.00
FNV.TO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 6602000000.00
FNV.TO income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 97500000.00
FNV.TO balance_sheet (quarterly, 2025-06-30) — Current Assets: 357300000.00
FNV.TO balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 84000000.00
FNV.TO cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 37200000.00
FNV.TO cash_flow (quarterly, 2025-06-30) — Deferred Tax: 37200000.00
FNV.TO cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 64000000.00
FNV.TO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 193000000.00
FNV.TO income_statement (quarterly, 2025-06-30) — Diluted EPS: 1.28
FNV.TO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 247100000.00
FNV.TO income_statement (quarterly, 2025-06-30) — EBIT: 316500000.00
FNV.TO income_statement (quarterly, 2025-06-30) — EBITDA: 380500000.00
FNV.TO cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 6100000.00
FNV.TO cash_flow (quarterly, 2025-06-30) — End Cash Position: 160300000.00
FNV.TO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -66100000.00
FNV.TO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -930600000.00
FNV.TO cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of PPE: -42200000.00
FNV.TO income_statement (quarterly, 2025-06-30) — Gain On Sale Of Ppe: 0.00
FNV.TO income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 4100000.00
FNV.TO balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -13100000.00
FNV.TO income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 8500000.00
FNV.TO balance_sheet (quarterly, 2025-06-30) — Gross PPE: 5899800000.00
FNV.TO income_statement (quarterly, 2025-06-30) — Gross Profit: 271900000.00
FNV.TO income_statement (quarterly, 2025-06-30) — Impairment Of Capital Assets: -42200000.00
FNV.TO cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 45700000.00
FNV.TO balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 50400000.00
FNV.TO income_statement (quarterly, 2025-06-30) — Interest Expense: 800000.00
FNV.TO income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 800000.00
FNV.TO income_statement (quarterly, 2025-06-30) — Interest Income: 6600000.00
FNV.TO income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 6600000.00
FNV.TO cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 400000.00
FNV.TO balance_sheet (quarterly, 2025-06-30) — Inventory: 7000000.00
FNV.TO balance_sheet (quarterly, 2025-06-30) — Invested Capital: 6602000000.00
FNV.TO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -1338100000.00
FNV.TO balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 597800000.00
FNV.TO balance_sheet (quarterly, 2025-06-30) — Loans Receivable: 17800000.00
FNV.TO cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: -5200000.00
FNV.TO income_statement (quarterly, 2025-06-30) — Net Income: 247100000.00
FNV.TO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 247100000.00
FNV.TO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 247100000.00
FNV.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 247100000.00
FNV.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 247100000.00
FNV.TO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 247100000.00
FNV.TO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 247100000.00
FNV.TO income_statement (quarterly, 2025-06-30) — Net Interest Income: 5800000.00
FNV.TO cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 12800000.00
FNV.TO income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 5800000.00
FNV.TO cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 10000000.00
FNV.TO balance_sheet (quarterly, 2025-06-30) — Net PPE: 5899800000.00
FNV.TO cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -1360900000.00
FNV.TO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 6602000000.00
FNV.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 25700000.00
FNV.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 311600000.00
FNV.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 25700000.00
FNV.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 311600000.00
FNV.TO balance_sheet (quarterly, 2025-06-30) — Non Current Note Receivables: 82500000.00
FNV.TO income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 334000000.00
FNV.TO income_statement (quarterly, 2025-06-30) — Normalized Income: 210704212.86
FNV.TO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 430300000.00
FNV.TO cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -47400000.00
FNV.TO income_statement (quarterly, 2025-06-30) — Operating Income: 263400000.00
FNV.TO income_statement (quarterly, 2025-06-30) — Operating Revenue: 369400000.00
FNV.TO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 192701088.00
FNV.TO balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 25500000.00
FNV.TO balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -13100000.00
FNV.TO income_statement (quarterly, 2025-06-30) — Other Gand A: 5700000.00
FNV.TO income_statement (quarterly, 2025-06-30) — Other Income Expense: 46500000.00
FNV.TO cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 130900000.00
FNV.TO balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 57500000.00
FNV.TO balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 10000000.00
FNV.TO income_statement (quarterly, 2025-06-30) — Other Special Charges: 3900000.00
FNV.TO balance_sheet (quarterly, 2025-06-30) — Payables: 84000000.00
FNV.TO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 84000000.00
FNV.TO income_statement (quarterly, 2025-06-30) — Pretax Income: 315700000.00
FNV.TO cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 900000.00
FNV.TO cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -3000000.00
FNV.TO cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -1360900000.00
FNV.TO balance_sheet (quarterly, 2025-06-30) — Receivables: 164500000.00
FNV.TO income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 97500000.00
FNV.TO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 64000000.00
FNV.TO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 806600000.00
FNV.TO income_statement (quarterly, 2025-06-30) — Salaries And Wages: 2800000.00
FNV.TO cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 15800000.00
FNV.TO cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 0.00
FNV.TO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 8500000.00
FNV.TO balance_sheet (quarterly, 2025-06-30) — Share Issued: 192701088.00
FNV.TO income_statement (quarterly, 2025-06-30) — Special Income Charges: 42400000.00
FNV.TO cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 1000000.00
FNV.TO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 6602000000.00
FNV.TO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 6602000000.00
FNV.TO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 10104212.86
FNV.TO income_statement (quarterly, 2025-06-30) — Tax Provision: 68600000.00
FNV.TO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.22
FNV.TO balance_sheet (quarterly, 2025-06-30) — Total Assets: 7020600000.00
FNV.TO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 6602000000.00
FNV.TO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 6602000000.00
FNV.TO income_statement (quarterly, 2025-06-30) — Total Expenses: 106000000.00
FNV.TO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 418600000.00
FNV.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 6663300000.00
FNV.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 334600000.00
FNV.TO income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 305800000.00
FNV.TO balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 50400000.00
FNV.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items: 46500000.00
FNV.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 46500000.00
FNV.TO balance_sheet (quarterly, 2025-06-30) — Tradeand Other Payables Non Current: 13000000.00
FNV.TO balance_sheet (quarterly, 2025-06-30) — Working Capital: 273300000.00
FNV.TO income_statement (quarterly, 2025-06-30) — Write Off: -4100000.00
FNV.TO income_statement (quarterly, 2025-09-30) — +Operating Expense: 16300000.00
FNV.TO income_statement (quarterly, 2025-09-30) — +Total Revenue: 487700000.00
FNV.TO balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 66100000.00
FNV.TO balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 190700000.00
FNV.TO balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 20200000.00
FNV.TO cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: -700000.00
FNV.TO cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 160300000.00
FNV.TO cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -292400000.00
FNV.TO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 5799600000.00
FNV.TO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 236700000.00
FNV.TO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 236700000.00
FNV.TO cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -67300000.00
FNV.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -64200000.00
FNV.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -208000000.00
FNV.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 348000000.00
FNV.TO cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: -5200000.00
FNV.TO cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 4500000.00
FNV.TO cash_flow (quarterly, 2025-09-30) — Change In Receivables: -44000000.00
FNV.TO cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -44700000.00
FNV.TO cash_flow (quarterly, 2025-09-30) — Changes In Cash: 75800000.00
FNV.TO balance_sheet (quarterly, 2025-09-30) — Common Stock: 5799600000.00
FNV.TO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 6999300000.00
FNV.TO income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 134200000.00
FNV.TO balance_sheet (quarterly, 2025-09-30) — Current Assets: 542500000.00
FNV.TO balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 116900000.00
FNV.TO cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 36600000.00
FNV.TO cash_flow (quarterly, 2025-09-30) — Deferred Tax: 36600000.00
FNV.TO cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 87000000.00
FNV.TO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 287500000.00
FNV.TO income_statement (quarterly, 2025-09-30) — EBIT: 363200000.00
FNV.TO income_statement (quarterly, 2025-09-30) — EBITDA: 450200000.00
FNV.TO cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 600000.00
FNV.TO cash_flow (quarterly, 2025-09-30) — End Cash Position: 236700000.00
FNV.TO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -64200000.00
FNV.TO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 55600000.00
FNV.TO cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: -12900000.00
FNV.TO cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of PPE: -3100000.00
FNV.TO income_statement (quarterly, 2025-09-30) — Gain On Sale Of Ppe: 3100000.00
FNV.TO income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 14200000.00
FNV.TO balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 101100000.00
FNV.TO income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 16300000.00
FNV.TO balance_sheet (quarterly, 2025-09-30) — Gross PPE: 6087100000.00
FNV.TO income_statement (quarterly, 2025-09-30) — Gross Profit: 353500000.00
FNV.TO cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 46800000.00
FNV.TO balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 50800000.00
FNV.TO income_statement (quarterly, 2025-09-30) — Interest Expense: 800000.00
FNV.TO income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 800000.00
FNV.TO income_statement (quarterly, 2025-09-30) — Interest Income: 8000000.00
FNV.TO income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 8000000.00
FNV.TO cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 1200000.00
FNV.TO balance_sheet (quarterly, 2025-09-30) — Inventory: 10300000.00
FNV.TO balance_sheet (quarterly, 2025-09-30) — Invested Capital: 6999300000.00
FNV.TO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -208000000.00
FNV.TO balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 774200000.00
FNV.TO cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 175000000.00
FNV.TO balance_sheet (quarterly, 2025-09-30) — Loans Receivable: 23700000.00
FNV.TO cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 175000000.00
FNV.TO cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -175000000.00
FNV.TO cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: -1700000.00
FNV.TO income_statement (quarterly, 2025-09-30) — Net Income: 287500000.00
FNV.TO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 287500000.00
FNV.TO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 287500000.00
FNV.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 287500000.00
FNV.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 287500000.00
FNV.TO cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 287500000.00
FNV.TO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 287500000.00
FNV.TO income_statement (quarterly, 2025-09-30) — Net Interest Income: 7200000.00
FNV.TO cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 84400000.00
FNV.TO cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 0.00
FNV.TO cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 0.00
FNV.TO income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 7200000.00
FNV.TO balance_sheet (quarterly, 2025-09-30) — Net PPE: 6087100000.00
FNV.TO cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -292400000.00
FNV.TO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 6999300000.00
FNV.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 24100000.00
FNV.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 369000000.00
FNV.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 24100000.00
FNV.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 369000000.00
FNV.TO balance_sheet (quarterly, 2025-09-30) — Non Current Note Receivables: 76900000.00
FNV.TO income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 432200000.00
FNV.TO income_statement (quarterly, 2025-09-30) — Normalized Income: 273220198.68
FNV.TO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 348000000.00
FNV.TO cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -17700000.00
FNV.TO income_statement (quarterly, 2025-09-30) — Operating Income: 337200000.00
FNV.TO income_statement (quarterly, 2025-09-30) — Operating Revenue: 487700000.00
FNV.TO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 192777097.00
FNV.TO balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 81100000.00
FNV.TO balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 101100000.00
FNV.TO income_statement (quarterly, 2025-09-30) — Other Gand A: 8600000.00
FNV.TO income_statement (quarterly, 2025-09-30) — Other Income Expense: 18000000.00
FNV.TO cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -1700000.00
FNV.TO balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 12100000.00
FNV.TO balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 8500000.00
FNV.TO balance_sheet (quarterly, 2025-09-30) — Payables: 116900000.00
FNV.TO balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 116900000.00
FNV.TO income_statement (quarterly, 2025-09-30) — Pretax Income: 362400000.00
FNV.TO cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 3100000.00
FNV.TO cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: 0.00
FNV.TO cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -292400000.00
FNV.TO balance_sheet (quarterly, 2025-09-30) — Receivables: 214400000.00
FNV.TO income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 134200000.00
FNV.TO income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 87000000.00
FNV.TO cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -175000000.00
FNV.TO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 1078400000.00
FNV.TO income_statement (quarterly, 2025-09-30) — Salaries And Wages: 7700000.00
FNV.TO cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 84400000.00
FNV.TO cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 0.00
FNV.TO income_statement (quarterly, 2025-09-30) — Selling General And Administration: 16300000.00
FNV.TO balance_sheet (quarterly, 2025-09-30) — Share Issued: 192777097.00
FNV.TO income_statement (quarterly, 2025-09-30) — Special Income Charges: 3800000.00
FNV.TO cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 1700000.00
FNV.TO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 6999300000.00
FNV.TO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 6999300000.00
FNV.TO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 3720198.68